Guide: Screening biologic candidates with nanoDSF
Read this guide about nanoDSF for high-resolution measurements of thermal stability parameters, common CQAs for biologics developability assessment.
List view / Grid view
Read this guide about nanoDSF for high-resolution measurements of thermal stability parameters, common CQAs for biologics developability assessment.
Stability attributes of biologic candidates are evaluated during early development workflows. Learn how to measure them with biophysical techniques.
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics.
Learn how Dianthus resolves common challenges you face during the characterization of PROTAC binary and ternary complexes and the determination of cooperativity.
In this infographic, we discuss both inhibition and degradation, the advantages and challenges related to each approach and the key points you need to consider when designing your protein degraders.
This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
Learn about DLS, a powerful method to characterise the purity and aggregation state of your biologics for improved candidate selection.
NanoTemper Technologies has announced the launch of Spectral Shift technology with its Dianthus instrument.
Learn why measuring binding affinity is key to helping you decide the next steps in your research and what technologies are available to measure it.
Learn how to measure protein stability, why it’s important, and what the key technologies are available to measure it.
Learn how fragment-based drug discovery improves hit rates and delivers higher-value targets using various biophysical methods.
Learn why researchers turned to biophysical methods to expose the molecular mechanisms of neurodegenerative diseases.
Learn practical tips from eight Principal Investigators about how to start your own lab.
Antisense oligonucleotides are an emerging therapeutic option for treating diseases with known genetic origin.
Current technologies that measure molecular interactions for drug discovery slow down and complicate screening. Dianthus is the answer to the demands for fast, non-stop, highly sensitive hit identification, hit validation and lead optimisation.